108 related articles for article (PubMed ID: 28350121)
1. Stanniocalcin 1 promotes cell proliferation via cyclin E1/cyclin‑dependent kinase 2 in human prostate carcinoma.
Bai Y; Xiao Y; Dai Y; Chen X; Li D; Tan X; Zhang X
Oncol Rep; 2017 Apr; 37(4):2465-2471. PubMed ID: 28350121
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
3. Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer.
Costa BP; Schein V; Zhao R; Santos AS; Kliemann LM; Nunes FB; Cardoso JCR; Félix RC; Canário AVM; Brum IS; Branchini G
Mol Cell Endocrinol; 2020 Feb; 502():110659. PubMed ID: 31816356
[TBL] [Abstract][Full Text] [Related]
4. HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2.
Li Y; Yang XH; Fang SJ; Qin CF; Sun RL; Liu ZY; Jiang BY; Wu X; Li G
Oncol Rep; 2015 Feb; 33(2):990-6. PubMed ID: 25501982
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.
Tang J; Chen Y; Cui R; Li D; Xiao L; Lin P; Du Y; Sun H; Yu X; Zheng X
Mol Med Rep; 2015 Dec; 12(6):7907-14. PubMed ID: 26496926
[TBL] [Abstract][Full Text] [Related]
6. Stanniocalcin 1 and ovarian tumorigenesis.
Liu G; Yang G; Chang B; Mercado-Uribe I; Huang M; Zheng J; Bast RC; Lin SH; Liu J
J Natl Cancer Inst; 2010 Jun; 102(11):812-27. PubMed ID: 20484106
[TBL] [Abstract][Full Text] [Related]
7. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
Yeung BH; Shek FH; Lee NP; Wong CK
PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.
Yang L; Fang D; Chen H; Lu Y; Dong Z; Ding HF; Jing Q; Su SB; Huang S
Oncotarget; 2015 Aug; 6(25):20801-12. PubMed ID: 26204491
[TBL] [Abstract][Full Text] [Related]
10. STC1 expression is associated with tumor growth and metastasis in breast cancer.
Chang AC; Doherty J; Huschtscha LI; Redvers R; Restall C; Reddel RR; Anderson RL
Clin Exp Metastasis; 2015 Jan; 32(1):15-27. PubMed ID: 25391215
[TBL] [Abstract][Full Text] [Related]
11. Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer.
Tamura K; Furihata M; Chung SY; Uemura M; Yoshioka H; Iiyama T; Ashida S; Nasu Y; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Sci; 2009 May; 100(5):914-9. PubMed ID: 19298603
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
13. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
Hayase S; Sasaki Y; Matsubara T; Seo D; Miyakoshi M; Murata T; Ozaki T; Kakudo K; Kumamoto K; Ylaya K; Cheng SY; Thorgeirsson SS; Hewitt SM; Ward JM; Kimura S
Thyroid; 2015 Apr; 25(4):425-36. PubMed ID: 25647164
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
15. ＜Editors' Choice＞
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Endo N
Nagoya J Med Sci; 2020 Feb; 82(1):85-92. PubMed ID: 32273636
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells.
Yeung HY; Lai KP; Chan HY; Mak NK; Wagner GF; Wong CK
Endocrinology; 2005 Nov; 146(11):4951-60. PubMed ID: 16109785
[TBL] [Abstract][Full Text] [Related]
17. SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability.
Ju LG; Zhu Y; Long QY; Li XJ; Lin X; Tang SB; Yin L; Xiao Y; Wang XH; Li L; Zhang L; Wu M
Cell Death Differ; 2019 Jun; 26(6):1156-1168. PubMed ID: 30237511
[TBL] [Abstract][Full Text] [Related]
18. Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.
Cheasley D; Pereira L; Sampurno S; Sieber O; Jorissen R; Xu H; Germann M; Yuqian Y; Ramsay RG; Malaterre J
Mol Cancer Res; 2015 Aug; 13(8):1185-96. PubMed ID: 25934694
[TBL] [Abstract][Full Text] [Related]
19. The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression.
Du YZ; Gu XH; Cheng SF; Li L; Liu H; Hu LP; Gao F
Tumour Biol; 2016 Apr; 37(4):5633-44. PubMed ID: 26577859
[TBL] [Abstract][Full Text] [Related]
20. Stanniocalcin-1 regulates re-epithelialization in human keratinocytes.
Yeung BH; Wong CK
PLoS One; 2011; 6(11):e27094. PubMed ID: 22069492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
